Skip to main content
HLX04, an alternative biosimilar to bevacizumab for refractory/metastatic colorectal cancer
Primary tabs
•••
View
Get Stamp Tags
Published Locations
Breadcrumb
Home
HLX04, an alternative biosimilar to bevacizumab for refractory/metastatic colorectal cancer
User login
Username
Password
Reset your password
Concept
Lead
score
Colorectal Cancer
1
1
Biologic Therapy
0
1
Angiogenesis Inhibitors
0
0.84
Humanized Monoclonal Antibody
0
0.84
Biosimilars
0
0.42
Refractory
0
0.32
Cancer
0
0.1
Specialty
Lead
score
Hematology-Oncology
1
1
Pharmacist
0
1
Gastroenterology
0
0.16
Edit Tags